Drug Side Effects
Search
METASTATIC SALIVARY GLAND CANCER
METASTATIC SALIVARY GLAND CANCER
was reported 36 times
METASTATIC SALIVARY GLAND CANCER is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Adenosine Receptor Agonist [EPC]
1
0.0001
1
Androgen Receptor Inhibitor [EPC]
8
0.0001
2
HER2/neu Receptor Antagonist [EPC]
7
0.0001
3
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
1
0.0001
4
Microtubule Inhibitor [EPC]
11
0.0001
5
Nitrofuran Antibacterial [EPC]
1
0.0001
6
Human Immunoglobulin G [EPC]
1
0.0000
7
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
8
Provitamin D2 Compound [EPC]
1
0.0000
9
Platinum-based Drug [EPC]
8
0.0000
10
RANK Ligand Inhibitor [EPC]
5
0.0000
11
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
12
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
13
Alkylating Drug [EPC]
4
0.0000
14
Arteriolar Vasodilator [EPC]
1
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
16
Azole Antifungal [EPC]
1
0.0000
17
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
18
Kinase Inhibitor [EPC]
3
0.0000
19
Interferon beta [EPC]
1
0.0000
20
Anti-epileptic Agent [EPC]
1
0.0000
21
Factor Xa Inhibitor [EPC]
1
0.0000
22
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
23
Vitamin B12 [EPC]
1
0.0000
24
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
25
Loop Diuretic [EPC]
1
0.0000
26
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
27
Corticosteroid [EPC]
2
0.0000
28
Tumor Necrosis Factor Blocker [EPC]
1
0.0000